Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Italy
  4. Borsa Italiana
  5. MolMed S.p.A.
  6. News
  7. Summary
    MLM   IT0001080248

MOLMED S.P.A.

(MLM)
SummaryChartsNewsCompanyFunds 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

MolMed Announces Transition of Luca Alberici from the Role of Chief Business Officer

10/12/2020 | 08:00am EST

AGC Biologics has announced a new appointment to initiate integration efforts resulting from the July 31, 2020 acquisition of MolMed. Effective immediately, Luca Alberici will transition from Chief Business Officer of MolMed to take on the role of General Manager/Site Head at the Milan, Italy site.


ę S&P Capital IQ 2020
All news about MOLMED S.P.A.
2022AGC Biologics and W.L. Gore & Associates Collaborate on New Protein A-Based Purificatio..
CI
2022RoosterBio and AGC Biologics Announce Collaboration to Accelerate Manufacturing of Cell..
CI
2021AGC Biologics Partners with BioNTech SE to Further Supply Plasmid DNA Starting Material..
CI
2020MolMed Announces Transition of Luca Alberici from the Role of Chief Business Officer
CI
2020Molmed S P A : CS_ integrativo del Comunicato dimissioni consiglieri
PU
2020MolMed S.p.A.(BIT:MLM) dropped from S&P Global BMI Index
CI
2020AGC Inc. completed the acquisition of 93.2% in MolMed S.p.A. from Finanziaria d'investi..
CI
2020Orchard Therapeutics and MolMed Announce Extension of Gene Therapy Manufacturing Collab..
CI
2020Italy to use vetting powers in Molmed acquisition by Japan's AGC
RE
2020University Of Tartu : Novel DNA analysis will help to identify food origin and counterfeit..
AQ
More news
Chart MOLMED S.P.A.
Duration : Period :
MolMed S.p.A. Technical Analysis Chart | MarketScreener
Full-screen chart
Managers and Directors
Patricio E. Massera Chief Executive Officer & Executive Director
Vijay Raghavan Senior Vice President-Global Finance
Noriyuki Komuro Chairman
Fabio Scoyni Chairman-Board of Statutory Auditors
Kasper M°ller Chief Technical Officer
Sector and Competitors
1st jan.Capi. (M$)
MOLMED S.P.A.0.00%282
MODERNA, INC.5.42%72 745
LONZA GROUP AG17.24%42 787
IQVIA HOLDINGS INC.12.00%42 622
ALNYLAM PHARMACEUTICALS, INC.-2.64%28 465
SEAGEN INC.9.46%26 117